Market reference for how much does a box of Baricitinib tablets cost?

Baricitinib (Baricitinib) is an oral JAK1/JAK2 inhibitor, originally jointly developed by Eli Lilly and Incyte for the treatment of moderately to severely active rheumatoid arthritis . Currently, the drug has been approved in many countries, including the United States, the European Union, Japan and China. Baricitinib is marketed in China under the trade name of "Alemin" and has been included in the national medical insurance catalog. It is one of the more widely used targeted immune drugs in recent years.

In clinical use, baricitinib is suitable for adult patients with rheumatoid arthritis who have an inadequate response to or are intolerant to one or moreTNF inhibitors. In addition, it was approved by the China Food and Drug Administration in 2022 for the treatment of severe alopecia areata and is the first oral drug that can systematically improve hair regeneration. At the same time, baricitinib is also used to treat patients hospitalized with COVID-19 and requiring oxygen therapy to suppress immune overreaction, improve lung inflammation, and promote recovery. Its mechanism of action is to inhibit the JAK-STAT signaling pathway, reduce the release of inflammatory factors, and thereby inhibit abnormal immune responses.

In the domestic market, Ailemin has been reimbursed by medical insurance, and the price is significantly lower than the original price. Reimbursement ratios vary slightly in different regions, and the average monthly out-of-pocket expenses of patients after medical insurance have dropped significantly. The original research version is produced by Eli Lilly and Company, and its specifications are usually 2mg or 4mg tablets, with 28 tablets per box. If calculated based on a 4 mg dose, the market price is approximately several thousand yuan, and the actual payment by patients after medical insurance is only a few hundred yuan.

In overseas markets, especially in countries such as Bangladesh, legal imitation versions have been launched. Each box of generic baricitinib produced by a well-known Bangladeshi pharmaceutical company usually contains 4 mg × 14 or 28 tablets. The price is about 200 to 300 yuan, and the drug ingredients are exactly the same as those of the original research. The price of overseas generic versions is much lower than that of domestic original drugs, providing more choices for some patients with limited financial conditions.

Reference materials:https://go.drugbank.com/drugs/DB11817

xa0